Drug companies can now engage in earlier and more comprehensive dialog with the European Medicines Agency, via a pilot project designed to help ensure their marketing authorization applications are well prepared and filed at the right time.
Drug companies can now engage in earlier and more comprehensive dialog with the European Medicines Agency, via a pilot project designed to help ensure their marketing authorization applications are well prepared and filed at the right time.